Exclusive Invitation: Private Investor Breakfast with i-Lumen Scientific

Dear Esteemed Investor,

Join us for an exclusive private investor breakfast to meet i-Lumen Scientific, Inc., a groundbreaking ophthalmology company revolutionizing the treatment of Dry Age-Related Macular Degeneration (Dry-AMD)—a condition affecting 1 in 4 people and the leading cause of blindness in those over 60.

📍 Fogo de Chão
201 3rd St Suite 100, San Francisco, CA
🗓 January 12, 2025 | 9:30 AM PST

Restoring Vision, Not Just Managing Disease

i-Lumen's non-invasive, office-based therapeutic has demonstrated unprecedented results:

• Over 50% of patients improved by 10+ letters on the ETDRS eye chart within 90 days.
• A meaningful step toward restoring vision—not merely slowing its decline.

De-risked Investment Opportunity

• Backed by clinical success in the US-based feasibility study (i-SIGHT) and preparing for the pivotal i-SIGHT2 study, i-Lumen is well-positioned for Class II De Novo clearance.

Rare Exit Potential in Ophthalmology

• Comparable acquisitions in this field have yielded 12-15x returns in 3-4 years.

• Series B Round: Raising $22 million, with $12 million already committed by Series A investors.

• Terms: Convertible preferred stock with a cumulative dividend, available at a $31.6 million pre-money valuation.
• Participation Options: Join with a $1,000,000 minimum or $50,000 minimum via SPV.

This is your chance to align with an innovative leader in ophthalmology poised to disrupt the market with a solution that improves vision and enhances quality of life.

Availability is reserved for qualified accredited investors on a first-come, first-served basis.

Secure your spot by registering here on Eventbrite.

We look forward to welcoming you to this exclusive briefing and to sharing i-Lumen's bold vision for the future of ophthalmology.

We will provide a confirmation email and a calendar invitation after you register.

Your attendance will be subject to client review and availability.

Thanks much and all the best,

The Opus8 Team

Host or Publisher Opus8 Private Events